For the COPD cases (Table 2B), the only difference between normal and AAT deficiency groups is a marginally (within standard deviation) higher plasma ACT level in the cases with MM AAT compared to those with ZZ AAT [t(17) = 2.5, p < 0.05)]. This evidence concerns the gene SERPINA3 and chronic obstructive pulmonary disease.